Characteristic pathological findings of achalasia behind unresectable esophageal cancer with pathological complete response after chemotherapy: a case report and literature review
Abstract
Background: Esophageal achalasia is a rare disease characterized by impaired peristalsis throughout the esophagus, marked esophageal dilation, and nonorganic stenosis of the lower esophagus due to degeneration of the Auerbach's plexus, and it is a known risk factor for esophageal cancer. To the best of our knowledge, this is the first reported case of achalasia‑associated advanced esophageal squamous cell carcinoma successfully treated using a multidisciplinary approach.
Case presentation: A 69-year-old female presented to our department with a 10-yr history of dysphagia and vomiting, accompanied by worsening hematemesis and passage disturbance. Esophagogastroduodenoscopy revealed a protruding lesion with stricture in the mid-to-lower thoracic esophagus, and biopsy confirmed squamous cell carcinoma. Further evaluation revealed unresectable advanced esophageal cancer with multiple lymph node metastases involving the dorsal descending aorta and left supraclavicular region. Following induction chemotherapy, marked shrinkage and disappearance of the primary tumor and metastatic lymph node were observed. However, nonorganic narrowing of the esophagogastric junction, along with esophageal tortuosity and dilation, persisted, leading to a diagnosis of esophageal achalasia. The patient subsequently underwent conversion thoracoscopic esophagectomy with the intent of achieving radical resection. Histopathological examination of the resected specimen demonstrated pathological complete…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.